Posted March 2017
Imagine Dragons lead singer, Dan Reynolds, appeared on March 8th on the syndicated talk show The Doctors to speak about living with…
A phase 2B clinical trial is now recruiting ankylosing spondylitis patients over the age of 18, who have been diagnosed before the age of 45, and have been experiencing symptoms for at least three months.
Posted February 2017
A recent study found a strong association between increased levels of an inflammatory marker in the gut and the subsequent development of Crohn’s disease in…
Posted January 2017
Biologic medications, such as TNF inhibitors (TNFi) and IL-17 inhibitors (IL-17i), are the current standard in rheumatologic treatment of moderate to severe spondyloarthritis. But what happens when patients don’t respond to this class of medications?
The following is an announcement from SAA about a third party clinical trial. SAA is not affiliated with this study, the researchers, or the drug manufacturer.
PO Box 5872
Sherman Oaks, CA 91413
(800) 777-8189 U.S. only
or (818) 892-1616